Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2005-12-7
pubmed:abstractText
Two chimeric enzymes, FLX and FLXLC, were designed and successfully overproduced in Aspergillus niger. FLX construct is composed of the sequences encoding the feruloyl esterase A (FAEA) fused to the endoxylanase B (XYNB) of A. niger. A C-terminal carbohydrate-binding module (CBM family 1) was grafted to FLX, generating the second hybrid enzyme, FLXLC. Between each partner, a hyperglycosylated linker was included to stabilize the constructs. Hybrid proteins were purified to homogeneity, and molecular masses were estimated to be 72 and 97 kDa for FLX and FLXLC, respectively. Integrity of hybrid enzymes was checked by immunodetection that showed a single form by using antibodies raised against FAEA and polyhistidine tag. Physicochemical properties of each catalytic module of the bifunctional enzymes corresponded to those of the free enzymes. In addition, we verified that FLXLC exhibited an affinity for microcrystalline cellulose (Avicel) with binding parameters corresponding to a Kd of 9.9 x 10(-8) M for the dissociation constant and 0.98 micromol/g Avicel for the binding capacity. Both bifunctional enzymes were investigated for their capacity to release ferulic acid from natural substrates: corn and wheat brans. Compared to free enzymes FAEA and XYNB, a higher synergistic effect was obtained by using FLX and FLXLC for both substrates. Moreover, the release of ferulic acid from corn bran was increased by using FLXLC rather than FLX. This result confirms a positive role of the CBM. In conclusion, these results demonstrated that the fusion of naturally free cell wall hydrolases and an A. niger-derived CBM onto bifunctional enzymes enables the increase of the synergistic effect on the degradation of complex substrates.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/16332795-10449312, http://linkedlifedata.com/resource/pubmed/commentcorrection/16332795-10508057, http://linkedlifedata.com/resource/pubmed/commentcorrection/16332795-10990025, http://linkedlifedata.com/resource/pubmed/commentcorrection/16332795-11000429, http://linkedlifedata.com/resource/pubmed/commentcorrection/16332795-11055947, http://linkedlifedata.com/resource/pubmed/commentcorrection/16332795-11082184, http://linkedlifedata.com/resource/pubmed/commentcorrection/16332795-11495573, http://linkedlifedata.com/resource/pubmed/commentcorrection/16332795-11729262, http://linkedlifedata.com/resource/pubmed/commentcorrection/16332795-11879047, http://linkedlifedata.com/resource/pubmed/commentcorrection/16332795-11902973, http://linkedlifedata.com/resource/pubmed/commentcorrection/16332795-11931668, http://linkedlifedata.com/resource/pubmed/commentcorrection/16332795-12702357, http://linkedlifedata.com/resource/pubmed/commentcorrection/16332795-12743752, http://linkedlifedata.com/resource/pubmed/commentcorrection/16332795-1398220, http://linkedlifedata.com/resource/pubmed/commentcorrection/16332795-14615854, http://linkedlifedata.com/resource/pubmed/commentcorrection/16332795-1479914, http://linkedlifedata.com/resource/pubmed/commentcorrection/16332795-15006424, http://linkedlifedata.com/resource/pubmed/commentcorrection/16332795-15294290, http://linkedlifedata.com/resource/pubmed/commentcorrection/16332795-15574891, http://linkedlifedata.com/resource/pubmed/commentcorrection/16332795-15705576, http://linkedlifedata.com/resource/pubmed/commentcorrection/16332795-16091777, http://linkedlifedata.com/resource/pubmed/commentcorrection/16332795-1678, http://linkedlifedata.com/resource/pubmed/commentcorrection/16332795-2513881, http://linkedlifedata.com/resource/pubmed/commentcorrection/16332795-2744487, http://linkedlifedata.com/resource/pubmed/commentcorrection/16332795-3472035, http://linkedlifedata.com/resource/pubmed/commentcorrection/16332795-7805053, http://linkedlifedata.com/resource/pubmed/commentcorrection/16332795-7831281, http://linkedlifedata.com/resource/pubmed/commentcorrection/16332795-7972069, http://linkedlifedata.com/resource/pubmed/commentcorrection/16332795-8140088, http://linkedlifedata.com/resource/pubmed/commentcorrection/16332795-8376323, http://linkedlifedata.com/resource/pubmed/commentcorrection/16332795-8979352, http://linkedlifedata.com/resource/pubmed/commentcorrection/16332795-9139893, http://linkedlifedata.com/resource/pubmed/commentcorrection/16332795-9335165, http://linkedlifedata.com/resource/pubmed/commentcorrection/16332795-9406381
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0099-2240
pubmed:author
pubmed:issnType
Print
pubmed:volume
71
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
8132-40
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2005
pubmed:articleTitle
Construction of engineered bifunctional enzymes and their overproduction in Aspergillus niger for improved enzymatic tools to degrade agricultural by-products.
pubmed:affiliation
UMR 1163 INRA/Université de Provence de Biotechnologie des Champignons Filamenteux, IFR-IBAIM, Universités de Provence et de la Méditerranée, ESIL, 163 Avenue de Luminy, Case Postale 925, 13288 Marseille Cedex 09, France. anthony.levasseur@esil.univ-mrs.fr
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't